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Abstract: In this preliminary study, the silver nanoparticle (Ag NP)-based dressing, 
Acticoat™ Flex 3, has been applied to a 3D fibroblast cell culture in vitro and to a real 
partial thickness burn patient. The in vitro results show that Ag NPs greatly reduce 
mitochondrial activity, while cellular staining techniques show that nuclear integrity is 
maintained, with no signs of cell death. For the first time, transmission electron 
microscopy (TEM) and inductively coupled plasma mass spectrometry (ICP-MS) analyses 
were carried out on skin biopsies taken from a single patient during treatment. The results 
show that Ag NPs are released as aggregates and are localized in the cytoplasm of 
fibroblasts. No signs of cell death were observed, and the nanoparticles had different 
distributions within the cells of the upper and lower dermis. Depth profiles of the Ag 
concentrations were determined along the skin biopsies. In the healed sample, most of the 
silver remained in the surface layers, whereas in the unhealed sample, the silver penetrated 
more deeply. The Ag concentrations in the cell cultures were also determined. Clinical 
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observations and experimental data collected here are consistent with previously published 
articles and support the safety of Ag NP-based dressing in wound treatment. 
Keywords: silver; nanoparticles; ICP-MS; SEM; TEM; Acticoat™ Flex 3; in vivo; in vitro; 
cytotoxicity; mitochondrial toxicity 
 
1. Introduction 
For centuries, silver compounds and ions have been extensively used for both hygienic and healing 
purposes, due to their strong bactericidal effects, as well as a broad spectrum antimicrobial  
activity [1,2]. Taking advantage of its bactericidal properties, various silver-containing preparations 
have been used for the treatment of chronic wounds. In the 17th and 18th centuries, silver nitrate was 
already used for ulcer treatment, and in 1960, it was introduced for the management of burns. After a 
decrease in the use of silver salts consequent to the introduction of antibiotics in 1940, in more recent 
years, there has been a renewed interest in silver, due to increased resistance of bacteria to antibiotics 
and improvements in polymer technology. This has resulted in a large number of silver-containing 
dressings being available on the market. Silver is applied to burns, either in the form of impregnated 
bandages or as a cream containing silver sulfadiazine as the active agent, a product that is still 
considered the benchmark silver product [3]. At the end of the 1990s, several Ag-containing dressings 
from different manufacturers appeared in commerce. Silver-based dressings are now available as a 
variety of fibers or polymeric scaffolds impregnated or coated with a Ag salt or metallic Ag in 
nanoparticulate form. They all exhibit fast and broad spectrum antibacterial activity against both 
Gram-positive and -negative bacteria [4,5]. In recent years, the mechanism of action of silver has been 
investigated: it seems that silver shows a multilevel antibacterial effect, due to blockage of respiratory 
enzyme pathways, as well as alteration of microbial DNA and the cell wall [6]. Silver has been 
demonstrated to be effective also against multidrug-resistant organisms [7,8], whilst maintaining a low 
systemic toxicity [9]. Clinically, several studies have confirmed their safety for patients [10,11] and 
concerns about their cytotoxicity on fibroblasts and keratinocytes have not been confirmed [12–14]. 
Nanoparticles (NPs) are defined as particles having one or more dimensions in the order of 100 nm 
or less. Silver NPs (Ag NPs) have been shown to possess unusual physical, chemical and biological 
properties [15–17]. The effectiveness of Ag NP-containing dressings has been widely tested in vitro, 
and much research work has been published recently demonstrating that these dressings have a fast 
and broad spectrum antibacterial activity against both Gram-positive and -negative bacteria [18,19]. 
However, up to now, the number of in vivo studies has been limited [20,21]. Even though  
Ag NPs-containing dressings are declared to be safe for patients and non-cytotoxic [22–24], recent 
studies have shown possible toxic effects on human fibroblasts and keratinocytes [25,26]. The 
cytotoxic effects that have been observed in different cell lines in vitro include decreases in 
mitochondrial function [27], cellular shrinkage and irregular shape [28], as well as production of 
reactive oxygen species (ROS) [29,30]. Carlson et al. found that ROS production was particle size, as 
well as concentration dependent [31], whilst Hackenberg and co-workers found that Ag NPs induce 
DNA damage in human mesenchymal stem cells [32]. 
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Considering the effective antibacterial properties of Ag NPs and the enormous interest in their 
application as coatings for medical devices and in wound therapy, their safety and biocompatibility 
need to be urgently clarified. We present here an in-depth study of a Ag NPs containing dressing. The 
product chosen is a flexible polyethylene cloth coated with nanocrystalline Ag particles and is one of 
the most widely used Ag based dressings in burns centers worldwide. The dressing was developed to 
guarantee a controlled and prolonged release of nanocrystalline silver [33] to the wound area; 
according to the manufacturer, the nanosilver particles also release silver ions. Physical vapor 
deposition was used to coat the polyethylene with nanocrystals that have a mean diameter of  
10–15 nm [34–36]. Previously published in vitro studies regarding the safety of this product have been 
carried out on human derived skin cells [37,38] and are in contrast with in vivo studies [39,40] and 
with daily observation of patients treated with this dressing [41]. 
In an attempt to clarify matters, our research work was carried out in vitro on a three dimensional 
cell culture system of human skin fibroblasts [42,43], as well as in vivo on skin biopsies from burns 
patients. The dressing was applied onto the cells and was changed every three days to simulate 
dressing changes by a clinician. The Ag concentration in the culture medium and in the used dressings 
has been measured by inductively coupled plasma mass spectrometry (ICP-MS), and the Ag amount 
absorbed by the cells has been evaluated by difference. Biochemical and morphological techniques 
have been employed to determine both the viability and the spatial distribution of the cells during the 
application of the dressing. In order to compare in vitro with in vivo results, skin biopsies were taken 
from a patient at different times during the healing process. These samples were subjected to 
histological analysis, and transmission electron microscopy (TEM) analyses were performed to 
determine the distribution profile of Ag NPs and their subcellular localization. 
Our in vitro results confirm that Ag NPs alter mitochondrial functionality in human fibroblasts, but 
interestingly, this does not seem to lead to cell death. Despite the reduced metabolic activity, we 
demonstrate that the cells are still viable, as no features of apoptosis were detected. We retain that the 
apparent cytotoxicity observed by other authors is probably an artifact of the use of a mitochondrial 
specific activity assay that is an indirect measure of cells viability. 
Our results suggest that mitochondria are activated to protect the cell and, in particular, the nucleus, 
against the action of Ag NPs. In vivo results demonstrate that application of Ag NP-based dressings 
allows wound healing and recovery. For the first time, it has been demonstrated that during application 
of Ag NP-based dressings on real patients, Ag NPs are released and enter into the cells as 
agglomerates. The Ag NPs do not dissolve entirely, but remain in the fibroblasts’ cytoplasm during the 
whole healing process and change shape over time. This effectively demonstrates the safety of 
Acticoat™ Flex 3, a Ag NP-based product currently used in burn care. Although Ag NPs treatment 
reduces mitochondrial activity, it does not appear to affect cell viability. Hence the Ag NPs released 
could be defined as toxic to mitochondria, causing a temporary reduction in metabolic activity in the 
cell, without causing cell death. Cells remain viable and are able to re-proliferate once the silver is 
passivated, leading to reconstruction of the dermal tissue in vivo. 
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2. Results and Discussion 
2.1. In Vitro Study 
2.1.1. MTT Assay 
To investigate if Ag NPs could negatively affect the healing process, we evaluated their toxicity on 
fibroblasts in vitro. A collagen-based scaffold was employed as a support for a 3D cell culture of 
fibroblasts to obtain a dermal-like tissue. At three, six and nine days, MTT assays were carried out to 
assess the mitochondrial function in cells treated with Ag NPs. 
As reported in Figure 1, a time-dependent decrease in metabolic activity was observed in the cells 
treated with the Ag NP-based dressing. This confirms the ability of Ag NPs to impair mitochondrial 
function, as reported by Burd [12] and Foldbjerg [27]. 
Our results demonstrate that the mitochondrial activity rapidly decreases over the first three days of 
treatment. After three days of exposure to Ag NPs, the cells had only 17% ± 0.54% of mitochondrial 
functionality normalized to the untreated sample value. In the following three days, the relative 
mitochondrial activity decreased to 7% ± 0.01%. In the final three days of the experiment, the 
mitochondrial functionality relative to the untreated control dropped to 5% ± 0.03%. This indicates 
that the Ag NPs and silver ions heavily impair mitochondrial functionality, and this is probably 
correlated to the generation of ROS, in agreement with the results found by AshaRani [28] and  
Hsin [30]. 
Figure 1. Mitochondrial activity in silver nanoparticle (Ag NP)-treated 3D fibroblast 
cultures, (one sample n = 2 readings ± SD versus time). The mitochondrial activity in the 
treated samples is expressed as a percentage of the activity of the untreated samples. For 
each time point, MTT values were obtained from duplicate readings of a single sample. 
 
2.1.2. Morphological Analysis 
Morphological analyses were carried out to investigate nuclei morphology and cellular distribution 
within the scaffold. Hoechst dye was employed to stain the nuclei blue and was used to verify the 
nuclear integrity or the presence of any apoptotic features, such as chromatin condensation and 
fragmentation, as well as the presence of apoptotic bodies. Under UV light, the characteristic 
fluorescence at 461 nm allows the localization of the cells in the three dimensional matrix. To confirm 
the results obtained, YO-PRO®-1 staining was carried out. As reported in Figure 2a, in the untreated 
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3D fibroblast cultures (controls), the cells proliferated mainly on the surface, although some cells grew 
also inside. Therefore, the dermal-like tissue appears as a multilayer of cells, where the fibroblasts are 
able to proliferate during the course of the experiments (Figure 2b). No signs of apoptosis were 
detected (Figure 2c). 
The similar distribution of cells was seen in the Ag NP-treated samples (Figure 2d). Interestingly, 
despite the reduced mitochondrial functionality observed, the nuclei are still present and appear to be 
undamaged. There was no observable presence of apoptotic bodies or nuclear fragmentation  
(Figure 2e,f). These results are in agreement with those recently observed by Zanette et al. [26] in the 
HaCaT cell line, supporting the hypothesis that Ag NPs reduce mitochondrial functionality without 
seeming to cause genotoxicity and cell death. 
In Figure 3, a quantitative comparison of the number of live cells in the treated and untreated 3D 
cell cultures can be seen. The results show that the number of live cells increased with time at the same 
rate in both samples. The YO-PRO®-1 assay showed that there were no apoptotic cells visible in the 
sample treated with Ag NPs. 
Figure 2. Dermal-like tissue reconstructed in vitro. Cells, visible thanks to the Hoechst 
blue staining of the nuclei, can be seen inside the collagen-based scaffold and appear to be 
organized in layers. (a) Un-treated control after three days from the beginning of the 
experiments; (b) Untreated control at nine days; (c) Enlargement of selected area;  
(d) Ag NP-treated fibroblast at three days; (e) Ag NPs fibroblast at nine days;  
(f) Enlargement of selected area. 
 
  
Int. J. Mol. Sci. 2013, 14 4822 
 
 
Figure 3. Progression of cell growth in time in a 3D dermal-like tissue after Ag NPs 
treatment (dark grey) and in the control sample (light grey); mean value ± SD (n = 2) 
samples versus time. The count of the live cells in the sample is obtained as the sum of the 
live cells at various depths at each position. 
 
2.1.3. Ag Release and Distribution 
The level of Ag in the new unused dressings was 821 ± 20 µg cm−2 (n = 9). This result is in 
agreement with the value of 827 ± 58 µg cm−2 previously estimated by Rigo et al. [44] and 
demonstrates that the inter-batch variability is negligible for Acticoat™ Flex 3. Table 1 summarizes 
the concentrations of Ag, and it is expressed as µg of Ag per cm2 (µg cm−2) of culture covered with the 
dressing. This is reported as per individual application of the dressing. During the experiment, three 
consecutive applications of Ag NP-based dressing were carried out. For the second and third 
application, the old dressing was substituted with a new one and deposited on the same sample of the 
cell culture. Concurrently, the medium (cDMEM) was removed and substituted with the same volume 
of fresh medium. The level of Ag applied to the culture at each step was derived from the average 
concentration of the unused dressing (see above), considering that all the pieces applied had the same 
surface area (0.283 cm2, 6 mm diameter). The fraction corresponding to the used dressing (called 
Dressing in Table 1) is comprised of Ag that was never released and Ag that was released, but  
re-adhered to the surface in another form, e.g., small fragments of scaffold containing Ag stuck to the 
surface. The fraction medium represents the Ag released into the liquid medium, and the fraction 
culture was calculated by difference and represents the Ag captured by the 3D culture. 
For each individual application of the dressing, most of the Ag (~94%) was revealed to remain in 
the dressing. The result is compatible with those previously obtained for the release of Ag in  
solution [44], where 94%–99% of Ag was found to still be present in the dressing after three days, 
depending on the composition of the solution. In this study, the fraction with the smallest silver 
concentration is the cell culture. Although the concentration is low, it is not irrelevant: the cumulative 
value reaches 68 ± 7 µg cm−2 (n = 3) after nine days of treatment. Although the cell culture was not 
changed at each three-days (unlike the dressing and the medium), the absorption rate of Ag increased 
from 18 ± 3 µg cm−2 (n = 9) in the first step to 25 ± 2 µg cm−2 (n = 6) in the second and 25 ± 3 µg cm−2 
(n = 3) in the third steps. Such an inverse trend between Ag and relative mitochondrial activity  
(see Figure 1) levels in the culture seems to confirm their direct causal relationship. The fraction of Ag 
released in the medium follows an opposite trend with decreasing values from the first to the second 
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step. This can be explained by the fact that the dressing releases a constant quantity of Ag into the 
medium, but cellular uptake increases in the second and third steps. In order to validate the indirect 
estimates of Ag concentration in the cell cultures reported in Table 1, the Ag concentrations in the 
samples used for the MTT analyses were determined by ICP-MS by analyzing the MTT and iDMSO 
fractions. These direct measurements and their sum are reported below in Table 2 and are compared 
with the estimated results obtained above. 
Table 1. The results for three separate applications of Ag to the culture, expressed as µg of 
Ag per cm2 (µg cm−2) of culture covered dressing. Applied Ag levels are assumed to be 
equal, based on analysis of the new unused dressing. Silver concentrations in the dressings 
and the medium were determined by ICP-MS. The Ag concentration in the 3D culture was 
obtained by difference. 
  Ag (µg cm−2) 
Days Sample size Total applied Dressing Medium Culture * 
1–3 n = 9 821 767 ± 4 37 ± 5 18 ± 3 
3–6 n = 6 821 765 ± 3 31 ± 3 25 ± 2 
6–9 n = 3 821 765 ± 4 32 ± 2 25 ± 3 
Note: * calculated as the mean of the differences. 
Table 2. Cumulative concentration of Ag (µg cm−2) in the cell culture (n = 1) and control 
experiment (n = 3) with a comparison of the values estimated by difference with the  
sum of the direct measurements in the MTT and dimethyl sulfoxide in isopropanol  
(iDMSO) fractions. TMAH: tetramethylammonium hydroxide. 
Days Estimated MTT + iDMSO MTT iDMSO TMAH 
3 16.5 16.3 5.8 10.5 - 
6 40.9 30.9 8.0 22.9 - 
9 62.9 46.5 10.3 36.2 - 
Control experiment in absence of cells n = 3 replicates ± 1 SD 
3 - 12.5 ± 5.1 8.9 ± 3.7 3.3 ± 1.8 0.7 ± 0.3 
The direct determination of Ag in the cell cultures resulted in levels lower than the indirect 
estimates, which are derived from the mass balance of the metal. It should be noted that the direct 
determinations are based on single replicates, so an uncertainty value cannot be provided. The 
underestimation is probably due to a non-quantitative recovery of Ag by the two extractions (in MTT 
buffer and iDMSO), so that part of Ag probably remains bound to the scaffold. We have shown that 
the accurate direct determination of Ag in the culture would require a separate replicate of the 
experiment. The indirect determination of Ag is a viable alternative to describe the kinetics of Ag 
distribution in the system, reducing the amount of time and materials required. The fraction extracted 
into iDMSO is always greater than that in MTT, and the proportion increases almost linearly between 
the third to the ninth day of treatment. 
In the control experiment, the Ag amount measured in the MTT fraction is 70% of the total and is 
similar to the Ag concentration found in the MTT fraction after six days, when fibroblasts were 
present. The amount of Ag measured in the iDMSO fraction is 25% of the Ag released and is much 
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less than found when cells are present, and the amount of Ag found after dissolution of the scaffold 
was found to be 5% of the total. This partitioning can be easily explained, because MatriDerm® is a 
dermal substitute made of elastin and collagen type I, III and V obtained from bovine nuchal ligaments 
(as stated by the manufacturer); these proteins have a limited number of cysteine residues. Therefore, 
Ag binds loosely to MatriDerm® and is easily extracted during the first extraction (MTT fraction). The 
Ag concentration in the MTT fraction should represent the amount of Ag loosely bound to the scaffold 
or the external surfaces of the cell membranes. It is well known that Ag has a strong interaction with 
DMSO [45] and that it causes cell lysis. So, it can be reasonably assumed that the Ag concentration in 
the iDMSO fraction represents the major part of the Ag fraction inside the cells, as well as being 
strongly bound to the structural constituents of the cells. This is confirmed by the control experiment 
that shows that the amount of Ag extracted by the iDMSO solution from the scaffold is always much 
less the value found when cells are present, and that complete dissolution of the scaffold only releases 
5% of the total Ag present. This demonstrates that most of the Ag released from the dressing over the 
nine days of the study is taken up by the cells or is adsorbed strongly to their surface. Considering that 
there is a linear increase of Ag in the iDMSO fraction during the experiment, we conclude that Ag 
uptake by the cells did not cease and that the cellular Ag binding sites either in or outside the cells had 
not been saturated. 
2.2. In Vivo Study 
2.2.1. Microscopy 
Optical microscopy observations of the skin biopsies after hematoxylin eosin staining show the 
main differences between the four samples. Figure 4a is burnt skin after surgical cleaning before silver 
application. Figure 4b is healed skin after seven days of treatment. Figure 4d is unhealed skin after 
seven days of treatment, and Figure 4f shows the same area healed after 17 days of treatment. 
Figure 4. Optical microscopy (OM) Images of the skin samples: burnt (a), healed after 
seven days (b and c), unhealed after seven days (d and e) and after complete  
re-epithelialization (f) after 10 more days of treatment. Healed and unhealed skin sections 
are shown with H/E and toluidine blue staining. Scale bar: 100 µm. 
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The burnt skin prior to Ag NP dressing application shows epidermal necrosis, diffuse perivascular 
infiltrate and important collagen degeneration at the level of the papillary dermis, characteristic of a 
deep dermal burn (Figure 4a). 
After seven days of treatment with Acticoat™ Flex 3, the structure of the biological tissue has been 
completely restored in the healed area (Figure 4b). Under staining with toluidine blue, it can be seen 
that the healed skin is composed of a well-stratified epidermis, complete with basal, spinous, granular 
and cornified layers (Figure 4c). Macroscopic evaluation shows more over the presence of a well 
vascularization at the dermal–subcutaneous interface. In the unhealed skin samples (Figure 4d,e), the 
tissue organization has not been re-established. The epidermis has not yet re-formed (Figure 4d) and 
the dermis still has a disorganized and irregular structure (Figure 4e). The wound was treated with 
Acticoat™ Flex 3 for 10 more days. When the dressing was removed, the wound appeared healed, and 
a new biopsy was taken to verify the re-establishment of the tissue architecture. Optical microscopy 
observations of the sample (Figure 4f) confirm the re-growth of the tissue structure, and in particular, it 
is possible to observe the restoration of the epidermis. This result of complete patient healing by the 
17th day shows that, despite the presence of Ag NPs in the tissue and inside the cells, the healing 
process does not seem to be impeded. Our results agree with and support the results recently published 
by Gravante et al. [46]. They found that Acticoat™ Flex 3 was the dressing with the shortest healing 
times for deep partial thickness burns (16 days average; our result, 17 days). The average healing times 
for sodium carboxymethyl cellulose were longer than those of nanocrystalline silver (21 days), but 
were shorter than paraffin gauzes (26.5 days) and collagenase cream (29 days). This data confirms that 
the healing process is not impeded during the treatment with Ag NPs. 
TEM images of the healed skin sample after seven days are shown in (Figure 5a–g). The sample 
was observed from the epidermis to a point at which Ag NPs were no longer visible, which 
corresponded to a depth of ~3 mm. In Figure 5a, the presence of a great number of agglomerates of 
nanoparticles can be seen surrounding the fibroblasts in the upper part of the dermis. No Ag NPs or 
aggregates were visible in epidermis. A higher magnification of the same area shows that the 
aggregates are located in the extracellular matrix, close to the cell membrane. In Figure 5b, as 
described by Xu [47], a slight broadening of the intercellular space can occur and is probably due to a 
previous inflammatory phase. In Figure 5c, it can be seen that agglomerates of Ag NPs enter into the 
cells via endocytic vesicles in the form of agglomerates, as recently observed separately by Kim [48] 
and Greulich [49] in different cell lines. The individual nanoparticles that are visible were measured to 
have diameters of <10 nm (Figure 5d). After the agglomerates were released into the cytoplasm 
(Figure 5e), they typically had a round shape and were located close to the mitochondria (labeled M). 
No Ag NPs were detected inside the nucleus (labeled NM), and no fragmented nuclei were observed. 
Despite the presence of Ag NPs inside the cytoplasm, the nuclear membrane is intact and is round in 
shape. The nucleolus visible in Figure 5b (labeled N) confirms that the chromatin is not condensed, but 
that it has a structure that allows transcription to proceed. In Figure 5e, it was observed that the 
mitochondria are generally located in the proximity of the nuclear membrane. 
It was observed that the fibroblasts in the upper part of the dermis seem to possess a particular 
spatial distribution of mitochondria. We speculate that these organelles have been replicated and then 
moved by the microtubules [50,51] to surround the nucleus to protect the DNA from possible damage 
caused by Ag NPs. It has been already demonstrated in different cell lines that Ag NPs are capable of 
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generating ROS inside the cells [29,31] that could damage the genetic material [32]. We hypothesize 
that once the Ag NPs have been released into the cytoplasm, they generate ROS. This could result in 
an increase in the number of mitochondria as a response to oxidative stress, as demonstrated by  
Lee et al. [52], to try and compensate for the reduced activity, as seen in Figure 3. We speculate that 
mitochondria are moved by the microtubules around the nucleus to act as a physical, as well as 
“chemical”, barrier to prevent ROS and Ag NPs from reaching the nuclear membrane. If the 
mitochondrial membrane breaks down due to the action of ROS, antioxidative enzymes, such as 
mitochondrial superoxide dismutase (mtSOD), catalase, glutathione peroxidase and thioredoxin 
peroxidase [53], are released from the mitochondria in the cytoplasm to quench the ROS. It has been 
already demonstrated that Ag NPs and Ag ions cause increased levels of SOD in human [54] and  
yeast [55] cells and that in vitro, the administration of ROS scavengers (such as SOD, catalase, 
mannitol and sodium selenite) can partially block the genotoxic effects of Ag NPs in human bronchial 
epithelial cells [54]. 
Figure 5. TEM images of the healed skin sample. (a) epidermis and dermis; (b) detail of a 
fibroblast surrounded by Ag NPs, in the upper part of the dermis; (c) endocytic vesicle 
containing Ag NP agglomerates; (d) magnification of endocytic vesicle containing Ag NP 
agglomerates; (e) Ag NPs have been released into the cytoplasm of a fibroblast and are 
located near the mitochondria; (f) a fibroblast in the lower part of the dermis—Ag NP 
aggregates are near the nuclear membrane; (g) a healthy undamaged mitochondrion.  
Key: DE, dermis; EP, epidermis; EV, endocytic vesicle; IS, intercellular space;  
M, mitochondrion; N, nucleolus; NM, nuclear membrane. Arrows indicate Ag NP 
agglomerates. Scale bars: (a) 500 nm; (b) 1 µm; (c) 100 nm; (d) 20 nm; (e) 200 nm;  
(f) 1 µm; (g) 100 nm. 
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In the lower part of the dermis (Figure 5f,g), the Ag NP agglomerates have a different shape and 
location inside the fibroblast, compared to what has been found in the upper stratus of the dermis. The 
agglomerates appear elongated and are located very close to the nuclear membrane. The mitochondria 
(labeled M) are generally distant from the agglomerates, indicated with an arrow, and appear to be 
undamaged and healthy (Figure 5g). 
As Acticoat™ Flex 3 was applied to the surface of the burn, the cells in the wound bed (lower part 
of the dermis) were the first to receive the Ag NPs released from the dressing. These cells were 
exposed to Ag NP aggregates for a longer time with respect to fibroblasts of the upper part of the 
dermis. During this time period, the Ag NPs could have undergone chemical changes that passivated 
them or quenched their ROS generating ability. In light of this hypothesis, Ag NPs could remain inside 
the cells, without provoking toxic effects. This could explain the different spatial distribution of the  
Ag NP agglomerates in the fibroblasts of the upper and lower dermis, but further investigations  
are necessary. 
In the unhealed skin, the tissue structure is highly disorganized and the epidermis had not reformed. 
The TEM images in Figure 6a,b show vesicles containing electron-dense matter, but it was not 
possible to verify if this material contained Ag. Unlike in the healed skin, in the unhealed skin sample, 
it was not possible to identify nanoparticles. It is possible that the electron-dense matter is composed 
of Ag salts or Ag bound to proteins via thiol or selenide groups and then precipitated [56]. 
Figure 6. TEM images of the unhealed skin sample, DM (dark matter), contained in 
vesicle. Scale bar: 1 µm. 
 
The SEM analyses showed the presence of particles in the unhealed skin samples. As shown in 
Figure 7a, such particles have a diameter <10 µm. The EDS spectrum (Figure 7b) shows that the 
particles are composed of virtually pure Ag metal. In the healed skin sample, it was not possible to 
identify Ag in any form. This was probably due to the low sensitivity of the technique and the absence 
of Ag microparticles on the surface of the sample. However, Ag microparticles were identified by 
SEM-EDS in the skin sample collected after 17 days of treatment, when the previously unhealed part 
of the wound had returned to a healthy condition. 
  
DM 
DM 
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Figure 7. SEM images of the unhealed sample (a) and energy-dispersive X-ray 
spectroscopy (EDS) spectrum (b) of the particle indicated by the arrow. Scale bar: 50 µm. 
 
2.2.2. Ag Release and Depth Profiles 
The depth profiles of Ag concentrations in the healed and unhealed biopsies taken after seven days 
of treatment are shown in Figure 8. This shows that the level of Ag in the healed sample decreases 
rapidly from 50.8 ± 0.8 ng mg−1 to 6.0 ± 0.2 ng mg−1 between the first and second slices. This trend 
continues between the third and deepest slices, to reach a range between 0.04 and 0.1 ng mg−1. The 
superficial concentration of Ag in the unhealed sample after seven days of treatment was lower  
(37.5 ± 0.6 ng mg−1), but the drop in the concentration profile was more gradual, as the second and 
third slices still had high concentrations of the metal (29.8 ± 0.5 and 9.6 ± 0.2 ng mg−1, respectively) 
compared to the healed sample. The cumulative amount of Ag in the unhealed tissue was 223 ng, 
which is slightly higher than the value in the healed tissue of 171 ng. The sample that was collected 
after an additional 10 days of treatment had a Ag profile (not shown) similar to that of the healed tissue 
after seven-days of treatment, but with approximately double the concentrations: 110 ± 2, 31.0 ± 0.7 
and 13.2 ± 0.1 ng mg−1 in the first three slices, respectively. 
The comparison between the Ag profiles and the corresponding OM images of the biopsies is also 
shown in Figure 8. This allows us to correlate the penetration of the metal into the tissue with its 
structural organization. The healed skin sample has the organized structure of a well-reconstructed 
tissue. The Ag NP aggregates released from the dressing were not able to penetrate deeply into the 
tissue, so they remained immobilized, mainly in the upper stratum of dermis, where they were covered 
by newly grown keratinocytes. The unhealed skin, instead, has a messy and disorderly structure and 
the normal connective tissue organization has not yet been re-established. Fibroblasts are low in 
number and the connective tissue poorly formed. This means that the Ag NPs released by Acticoat™ 
Flex 3 are able to pass through the connective tissue to reach the lower strata of the dermis. As 
observed in the quantification of Ag in the in vitro MTT and iDMSO fractions (see above,  
Section 2.1.3), the Ag concentration in the skin samples increases linearly with the number of 
dressings applied on the wound. The same is seen in vivo; a skin sample treated with two pieces of 
Acticoat™ Flex 3 has double the Ag concentration of skin samples after only one application. The 
slightly higher cumulative Ag concentration measured in the unhealed skin sample after seven days of 
treatment can be explained by considering that the presence of body fluids and exudates can increase 
Ag release from dressings [56]. 
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Figure 8. Depth profiles of Ag concentration (ng mg−1) after seven days of treatment. In 
this pilot study, the biopsies were obtained from the same patient. One biopsy for silver 
analysis was taken from the healed part of the wound (top) and one from the unhealed 
(bottom) tissue. Panoramic images of the other duplicate sample were obtained by  
optical microscopy, and zoomed in areas of representative portions are also shown  
for comparison. 
 
 
2.2.3. Clinical Observations 
Our results are reinforced by the clinical observations that were collected between January 2011 to 
September 2012 in the Plastic Reconstructive Surgery Division. In this time interval, 98 patients were 
treated with Acticoat™ Flex 3 for coverage of burn wounds. A total of 102 applications, 
corresponding to 58,400 cm2 of dressing containing a total of nearly 48 g of high purity silver, were 
used. The annual use in 2011, which was the year of introduction of Acticoat™ Flex 3, was around 
33,000 cm2. Data from average monthly use in 2012 are comparable to 2011, and we foresee a stable 
annual use. The patients were 63 males and 45 females, with an average age of 49 years. Ninety-five 
patients received a single silver dressing application; three patients, two. Burning causes comprised of 
fire (55 patients), hot liquids (23, of which three were boiling oil) and others (six contact burns, four 
Int. J. Mol. Sci. 2013, 14 4830 
 
 
chemical burns). The average total body surface area (TBSA) burn percent was 23.6% ± 17.1%. Out of 
98 cases, 100% reached re-epithelialization. The average amount of dressing used per patient was 
602.4 ± 163.5 cm² (minimum 200 cm²; maximum 1100 cm²). Re-epithelialization was spontaneous in 
80 cases, and lesions were recorded as healed within 32 ± 18 days from the last silver dressing 
application. None of the patients in this study complained of pain or had any symptoms or signs 
suggesting argyria. None of the 98 patients treated with Acticoat™ Flex 3 between January 2011 to 
September 2012 in the Plastic Reconstructive Surgery Division was recorded to have staining of skin 
due to silver accumulation. Eighteen patients reached healing after autologous skin grafting. 
Autologous grafting was performed at 23 ± 9 days after the last silver dressing application. Healing 
times recorded for burn wounds are consistent with the data previously reported by other  
authors [34,57,58]. Khundkar et al. [20] demonstrated that Ag NP-based dressings are effective in 
reducing the time for re-epithelialization and the requirement for grafting in comparison to other 
treatment widely used in burn centers, such as silver sulfadiazine and 0.01% neomycin and polymyxin 
solution. Strand et al. [59] compared the length of stay for hospitalized patients treated with 
Acticoat™ Flex 3 with those treated with Mepitel, a flexible polyamide net coated with soft silicone. 
The authors found the mean in-patient stay was 12.5 days when treated with Mepitel, whilst the mean 
stay was 4.5 days when the patients were treated with nanocrystalline silver dressing. In our study, the 
percentage of patients (18%) that required skin grafting is limited and comparable to the results (8%) 
obtained by Strand et al. [59]. Literature data, clinical observations collected by the Plastic 
Reconstructive Surgery Division of Padua and the results obtained in this work on a limited number of 
samples support each other in confirming the safety of Acticoat™ Flex 3. 
2.2.4. Limits of This Study and Future Perspectives 
A major limit of this preliminary work is the number of in vitro and in vivo samples that were made 
available. In particular, it would be useful to verify the results of the MTT and YO-PRO®-1 assays on 
a larger number of samples and recruit more patients for the study. Another limit of this work is that 
the mitochondrial activity was only monitored for nine days, which was not long enough to verify the 
revival of mitochondrial activity that is suggested by our in vivo observations. To clarify this aspect, 
the in vitro experiments should be carried out for a prolonged time period (>17 days, time for complete 
healing in patients). The side effects and fate of Ag NPs remaining deposited in the healed skin after 
treatment are still unknown and should be investigated by patient follow-up in any future work. 
3 Material and Methods 
3.1. Dressing 
Acticoat™ Flex 3 (Smith & Nephew, Milan, Italy) dressing is a flexible polyethylene cloth coated 
with nanocrystalline Ag particles at a concentration between 0.69 and 1.64 mg/cm2. 
At the Plastic Reconstructive Surgery Division of the University Hospital of Padova, Acticoat™ 
Flex 3 is used for burn wounds with the indication of partial-thickness burn, which needs improvement 
of wound-bed quality for faster recovery. Acticoat™ Flex 3 is fixed with metallic sutures after 
performance of surgical toilette of the wounds. The gauze dressing over the wound is moistened with 
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distilled water and changed weekly. Patients are discharged from the hospital after taking into account 
their general condition; this is usually 7–10 days post-operation, and further, out-patient care is 
provided on a regular weekly basis. The Ag NP dressing is removed at around day 14. If the wound is 
recalcitrant, the patient is then subjected to further wound cleaning and autologous skin grafting. If 
reactivation of re-epithelialization from the edges is observed, the wound is treated with Vaseline® 
gauze plus Amukine Med 0.05% (a sodium hypochlorite cutaneous solution). 
3.2. In Vitro Study 
3.2.1. Cell Cultures 
Human dermal fibroblasts were prepared according to a modified version of the Rheinwald and 
Green protocol [60]. After epithelial sheet dispase removal, the dermis was cut into small pieces  
(2–3 mm2), and fibroblasts were isolated by sequential digestion with 0.25% w/v trypsin for 20 min 
and 0.25% w/v collagenase for 4 h. These cells were then cultured with Dulbecco’s Modified Eagle 
Medium (DMEM), (Lonza S.r.l., Milano, Italy) supplemented with 10% Fetal Bovine Serum (FBS) 
(Bidachem S.p.A., Milano, Italy) and 100 units/mL penicillin and 100 µg/mL streptomycin to form 
complete DMEM (cDMEM). The medium was changed twice a week, and the cells were harvested by 
trypsin treatment. After detachment from culture plates, fibroblasts were cultured in 3D collagen-based 
scaffolds (MatriDerm®, Dr. Suwelack Skin & Health Care AG, Billerbeck, Germany) at a density of 
1.2 × 105 cells/cm2, obtaining a reconstructed dermal-like tissue in vitro. The number of the cells used 
to seed was derived from previous studies by Zavan and co-workers [42,43,61]. Cells were grown in 
the 3D scaffold for 10 days in 800 µL of cDMEM. The Ag NP-based dressing was applied above the 
3D cell cultures. To guarantee experimental reproducibility, all the experiments were carried out using 
subsamples taken always from the same dressing and scaffold. Both the dressing and scaffold was cut 
with skin biopsy punches. For the dressing, a 6 mm internal diameter punch was used to obtain  
40 subsamples, whereas for the scaffold, an 8 mm internal diameter punch was employed to obtain  
15 subsamples. The flow chart of the experimental plan is reported in Figure 9. Every 3 days, the 
dressing was removed from the culture and substituted with a new one. Concurrently with dressing 
change, the culture medium was removed and replaced with fresh medium. 
As reported in Figure 9, one set of 9 control and 9 treated cultures was created. At fixed time points 
(3, 6, 9 days), an MTT assay was carried out on a control and treated sample to verify mitochondrial 
activity. Histological analyses were performed in duplicate to verify cell distribution within the 
collagen-based scaffold, in the control and Ag NP treated samples. Cell culture medium and the used 
dressings have been collected to quantify the Ag release by ICP-MS analysis, as reported in  
Section 3.4. 
  
Int. J. Mol. Sci. 2013, 14 4832 
 
 
Figure 9. Flow chart of the experimental plan adopted for the in vitro study. The cycle of 
applications is repeated to carry out the chemical, toxicological and mitochondrial 
functionality determinations for 3, 6 and 9 days of cumulative duration of the treatment. 
 
3.2.2. MTT Assay 
To determine the kinetics of cell growth with or without Ag NPs, the MTT-based  
(methyl-thiazolyl-tetrazolium) cytotoxicity assay was performed according to the method of Denizot 
and Lang with minor modifications [62]. This colorimetric assay is an indirect method for assessing 
cell growth and proliferation. MTT gives a yellowish aqueous solution, which, on reduction with 
dehydrogenases or reducing agents present in metabolically active cells, yields a violet-blue water 
insoluble dye compound, formazan. The lipid soluble formazan is extracted with organic solvents and 
quantified spectrophotometrically. The amount of MTT formazan produced is directly proportional to 
the metabolic activity of cells. 
After harvesting the culture medium, the cells were incubated for 3 h at 37 °C in 1 mL of  
0.5 mg/mL MTT solution prepared in phosphate buffer saline solution (PBS). After removal of the 
MTT solution by pipette, 0.5 mL of 10% dimethyl sulfoxide in isopropanol (iDMSO) was added to 
extract the formazan in the samples for 30 min at 37 °C. 
For each sample, absorbance values at 570 nm were recorded in duplicate on 200 µL aliquots 
deposited in microwell plates using a multilabel plate reader (Victor 3 Perkin Elmer, Milano, Italy). 
The mitochondrial functionality in the Ag NP-treated cells is calculated as the ratio between the 
absorbance at 570 nm of the treated sample and the absorbance of a control sample expressed as  
a percentage. 
3.2.3. Morphological Analysis 
Concurrently with the MTT assay, morphological analyses were carried out on the duplicate 
samples. After removing the Ag NP-based dressing and the culture medium, the remaining dermal-like 
tissue was embedded in Optimal Cutting Temperature (OCT) compound, frozen in liquid nitrogen and 
preserved at −80 °C until cutting. Tissue sections (>7 µm thickness) were obtained using a cryostat 
(CM1950, Leica, Milano, Italy) and deposited onto gelatin-coated glass slides. They were fixed with 
absolute acetone for 10 min at room temperature and cryopreserved at −20 °C until use. In order to 
visualize the cell distribution inside the scaffold and to investigate the possibility of nuclear 
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fragmentation, the fibroblasts nuclei were stained with Hoechst H33342 fluorochrome (Sigma Aldrich, 
Milano, Italy, final concentration of 2 µg/mL). The samples were observed using a Zeiss Axioplan 
fluorescence microscope equipped with a digital camera (DC500, Leica, Milano, Italy). 
In order to quantify the number of live cells and highlight the presence of apoptotic cells, a parallel 
set of in vitro experiments were carried out. Hoechst H33342 dye was added to the 3D dermal-like cell 
culture simultaneously with YO-PRO®-1 iodide dye (excitation wavelength 491 nm/emission 
wavelength 509 nm, Molecular Probes). Hoechst H33342 dye stains the nuclei in the whole population 
of cells, while YO-PRO®-1 stains specifically the apoptotic cells. YO-PRO®-1 is a green fluorescent 
probe, which can enter cells once their plasma membrane has reached a certain degree of permeability. 
The cell membrane during apoptosis becomes slightly permeable and YO-PRO®-1 can freely enter the 
cell and bind to its nucleic acids, enhancing its fluorescence intensity. The number of different cells 
was counted, and live cells are calculated as the difference between the number of cells stained with 
Hoechst H33342 and the number of apoptotic cells stained with YO-PRO®-1. Immediately after the 
removal of the Ag NP-based dressing from the 3D cell cultures, Hoechst 33342 and YO-PRO®-1 were 
added to the cell cultures. The cells were incubated at 37 °C for one hour, and then, the culture 
multiwell plate containing the cells was transferred to a confocal laser scanning microscope to monitor 
YO-PRO®-1 and Hoechst fluorescence. 
A fluorescence confocal laser scanning microscope (Axiovert 100M, Zeiss, Germany) with a 10× 
magnification objective was used for the detection of Hoechst H33342 and YO-PRO®-1 stained cells. 
The fluorescent dye, YO-PRO®-1, was excited with a 25 mW Argon laser at 488 nm. Emission was 
recorded above 510 nm. The Hoechst H33342 fluorescence was detected at 460 nm after excitation at 
346 nm. The microscope was equipped with a motorized stage, and the LSM 510 (Zeiss) software 
enabled memorization of stage positions. For each sample, images were taken at the preset stage 
positions at various depths. The count of the live cells in the sample is obtained as the sum of the live 
cells at various depths at each position. 
3.3. In Vivo Study 
3.3.1. Human Skin Samples 
Patients were eligible for the study if recruited <24 h post-burn injury and were affected by  
partial-thickness burns. Patients were excluded if they were affected by full thickness burns or had a 
compromised immune system or were known to be hypersensitive to silver and its compounds. 
Patients were also excluded in case of comorbidity (e.g., diabetes, cardiac or renal disease), chemical 
or electrical burns, multiple trauma or were aged <5 or >60. Skin biopsies were obtained from a set of 
eligible patients who gave consent for taking biopsy materials for scientific purposes, and the study 
was performed in compliance with the Declaration of Helsinki ethical guidelines. 
Biopsies were collected by using punches of 4 mm inner diameter × 7 mm depth, according to the 
experimental plan represented in Figure 10, from 1 patient. Duplicate samples were collected from the 
same patient before application of the dressing (time zero). After seven days of treatment at dressing 
removal, two more duplicates were taken, one from the healed area and another from an unhealed 
zone. After 10 more days of treatment with a new dressing, another duplicate sample was taken from 
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the newly healed area. For each sample, the first duplicate was preserved in formalin and then divided 
vertically into two portions: one was used directly for histological analysis after hematoxylin and eosin 
staining, while the other part was transferred into a 2.5% glutaraldehyde solution and, subsequently, 
prepared for analysis by transmission electron microscopy (TEM). The second duplicate was 
immediately frozen and then used for the environmental scanning electron microscopy (ESEM) and 
chemical analysis, as reported in Section 3.4. 
Figure 10. Flow chart of the experimental plan adopted for the in vivo study. 
 
3.3.2. Optical Microscopy, TEM and ESEM 
The samples preserved in formalin were used for histological analyses to evaluate the tissue 
structure during the course of the healing process. They were then paraffin-embedded, stained with 
hematoxylin and eosin and observed using optical microscopy (OM). 
To select the areas with the most altered cellular morphology and, hence, potential Ag localization, 
a preliminary morphological characterization of the other vertical portion was carried out on semi-thin 
sections after toluidine blue staining (1% toluidine blue 1% borax for OM). The selected areas were 
then re-sampled to provide information on the distribution of Ag NPs at the sub-cellular level. This is 
done by fixing in a 2.5% glutaraldehyde/0.1 M sodium cacodylate buffer overnight at 4 °C. The 
samples were then treated with 1% OsO4/0.1 M sodium cacodylate buffer and dehydrated using 
ethanol solutions of increasing concentrations before embedding in EPON™ epoxy resins. Ultrathin 
sections (ultramicrotome, LKB, Stockholm, Sweden) were obtained and treated with 1% uranyl acetate 
and 1% lead citrate. The samples were analyzed by TEM (Electronic Microscopy Service, Department 
of Biology, University of Padova, Padua, Italy) using a Tecnai G12 electron microscope (FEI, 
acceleration voltage 100 kV). The image acquisition system consisted of a video camera, TIETZ (Tietz 
Video and Image Processing Systems GmbH, Gauting, Germany), and the TIA FEI Imaging Software 
(FEI Company, Hillsboro, OR, USA). 
The ESEM analysis was carried out at the Interdepartmental Service Center C.U.G.A.S. (University 
of Padova) using a Quanta 200 (FEI company, Hillsboro, OR, USA) instrument equipped with an 
energy dispersive X-ray (EDAX Inc; Mahwah, NJ, USA) detector. Samples were dried in a 
thermostatted oven at 37 °C for 24 h prior to analysis. The samples were analyzed directly after 
placing on a vitreous carbon planchet, without metallization. Backscattered electron images were 
collected at 25 kV. Representative energy-dispersive X-ray spectroscopy (EDS) spectra were collected 
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in potentially interesting sites to obtain a qualitative indication of the elemental composition of the 
surface and particles identified in the samples. 
3.4. Determination of Ag Levels by ICP-MS 
The concentration of Ag in all samples (dressing, culture medium, cell culture extracts and in vivo 
collected skin) were determined by inductively coupled plasma-quadrupole-mass spectrometry  
(ICP-QMS) using a model 7500cx instrument from Agilent Technologies (Tokyo, Japan). The main 
instrumental parameters are reported in Table 3, whilst sample preparation is briefly outlined below. 
All reagents were purchased from Sigma-Aldrich, Milan, Italy. 
Table 3. Inductively coupled plasma-quadrupole-mass spectrometry (ICP-QMS)  
operating conditions. 
RF power 1500 W 
Plasma gas flow rate 15 L min−1 
Carrier gas flow rate 1.2 mL min−1 
Nebulizer V-groove 
Ions lens setting Optimized daily for best sensitivity using a  
10 ng mL−1 Ag in NH4OH 2.8% w/w solution 
Monitored masses 107, 109 
Points per peak 3 
Acquisition time per point 1 s 
Replicates 5 
New (unused) and residual dressings (collected after the in vitro application) were mineralized by 
acid digestion in an Ethos1 (Milestone) microwave oven. The digestion was carried out in Teflon 
vessels following a two step program by adding to ~2 mg of the samples 10 mL of concentrated HNO3 
(1st step at 200 °C, 50 min) and then 2 mL H2O2 30% w/w (2nd step at 200 °C, 10 min). The digests of 
the residual dressings were centrifuged at 3000 rpm for 10 min to separate the AgCl precipitate 
formed, due to the presence of Cl− in the cDMEM. The supernatant was collected and directly diluted 
in NH4OH 2.8% w/w, while the precipitate was dissolved in 1.5 mL of concentrated NH4OH  
(28% w/w) and then diluted in NH4OH 2.8% w/w for ICP-QMS analysis. 
The Ag concentration was also determined in cDMEM (~400 µL) collected from the cell culture 
(both untreated and treated with Ag NPs) used for MTT and histological analyses. The solutions were 
directly diluted in NH4OH 2.8%, tetramethylammonium hydroxide (TMAH) 0.1% and Triton-X 0.1% 
w/w and analyzed for total Ag by ICP-QMS, as above. 
The concentration of Ag in the cell culture (and the scaffold) was indirectly estimated by the 
difference between the level in the new dressing and the combined levels found in the residual dressing 
and in the medium. To validate the estimates, they were compared with the direct measurement of the 
Ag concentration in the cell cultures (plus scaffold) previously used for the MTT assay (the only  
non-destructive analysis). The Ag concentration in the cell culture and underlying scaffold was 
obtained as the sum of the concentrations measured in the fraction collected after MTT incubation and 
in the reunified iDMSO fractions after absorbance measurement. The iDMSO fraction was treated with 
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1.5 mL of NH4OH 28% w/w to solubilize any Ag attached to the scaffold; the sample was then 
centrifuged at 3000 rpm for 10 min. The supernatant was diluted to a final volume of 15 mL in TMAH 
0.1% and Triton-X 0.1%. The MTT fraction was first diluted (1 + 14) in a solution containing NH4OH 
2.8% TMAH 0.1% and Triton-X 0.1%. This solution was then used to dilute both fractions (200 times) 
prior to ICP-QMS analysis. A parallel control experiment at the 3 day time point in the absence of 
cells was carried out to quantify the partitioning of silver between the fractions described above and 
the scaffold. In this experiment, after extraction with iDMSO, 500 µL of concentrated ammonium 
hydroxide solution (28%, as sold by Sigma Aldrich) was added to the vial containing the  
collagen-based matrix and the iDMSO solution. To ensure that all the silver attached to the surface of 
the scaffold was removed, the vial was vigorously shaken for 1 min at room temperature. The solution 
was removed by pipette, and the collagen-based matrix was washed twice with 500 µL concentrated 
ammonium hydroxide solution to recover the amount of surface bound Ag from the scaffold and to 
solubilize any insoluble silver forms present (in particular, AgCl or silver bound to insoluble proteins, 
as reported in Rigo et al. [47]). All the collected fractions were reunified within the iDMSO fraction 
and analyzed by ICP-MS. The remaining scaffold was mineralized in 500 µL of concentrated TMAH 
(25% w/v in water) and was then analyzed by ICP-MS to quantify the amount of Ag trapped in the scaffold. 
Once the ESEM-EDS analysis was completed, the biopsies collected in vivo were cut into 
transverse sections of approximately 2 mg weight. Concentrated TMAH solution (100 µL) was added 
to each section, and alkaline digestion was carried out overnight in a thermostatic bath at 60 °C. The 
digests were diluted 200-fold in 0.1% Triton X-100 and NH4OH 2.8% w/w solution and analyzed for 
total Ag concentration by ICP-QMS, as reported above. 
4. Conclusions 
In this pilot study, in vitro results indicate the safety of Acticoat™ Flex 3. It seems that Ag NPs 
may reduce mitochondrial functionality, but this probably occurs temporarily. As indicated by our 
results, the reduction in mitochondrial activity does not affect cell viability. The in vivo study, although 
limited in scope, since it was conducted on a single patient, by taking a biopsy from an unhealed area 
and a healed area of the same wound, seems to support the absence of toxicity: in the healed skin, no 
signs of apoptosis or necrosis were observed, despite the presence of a great quantity of Ag NPs in the 
cytoplasm of the fibroblasts. We observed that a Ag NP-based dressing does not create an obstacle to 
the recovery of severe partial thickness burns. After application for an extended period (17 days), the 
organized skin structure (dermis and epidermis) was re-established in a previously unhealed part of the 
wound. In this pilot study, we have also demonstrated that the application of Ag NP-based dressings, 
even for a prolonged time, does not seem to negatively affect the proliferation of fibroblasts and 
keratinocytes, leading to the restoration of normal skin. 
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